Bcl-2 and the regulation of programmed cell death
暂无分享,去创建一个
[1] John Calvin Reed,et al. Apoptosis induced by withdrawal of interleukin-3 (IL-3) from an IL-3-dependent hematopoietic cell line is associated with repartitioning of intracellular calcium and is blocked by enforced Bcl-2 oncoprotein production. , 1993, The Journal of biological chemistry.
[2] R. Poulsom,et al. BCL‐2 expression in adult and embryonic non‐haematopoietic tissues , 1993, The Journal of pathology.
[3] C. Purdie,et al. Thymocyte apoptosis induced by p53-dependent and independent pathways , 1993, Nature.
[4] D. Bredesen,et al. The Protooncogene bcl‐2 Inhibits Apoptosis in PC12 Cells , 1993, Journal of neurochemistry.
[5] A. Fornace,et al. Induction of Cellular p53 Activity by DNA-Damaging Agents and Growth Arrest , 1993, Molecular and cellular biology.
[6] D. Green,et al. Role for c-myc in activation-induced apoptotic cell death in T cell hybridomas. , 1992, Science.
[7] M. Cleary,et al. Membrane topology of the Bcl-2 proto-oncogenic protein demonstrated in vitro. , 1990, The Journal of biological chemistry.
[8] Gerard I. Evan,et al. Induction of apoptosis in fibroblasts by c-myc protein , 1992, Cell.
[9] J. Sklar,et al. Detection of the t(14;18) at similar frequencies in hyperplastic lymphoid tissues from American and Japanese patients. , 1992, The American journal of pathology.
[10] M. Berger,et al. Characterization of A1, a novel hemopoietic-specific early-response gene with sequence similarity to bcl-2. , 1993, Journal of immunology.
[11] J. Lotem,et al. Regulation by bcl-2, c-myc, and p53 of susceptibility to induction of apoptosis by heat shock and cancer chemotherapy compounds in differentiation-competent and -defective myeloid leukemic cells. , 1993, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.
[12] John Calvin Reed,et al. bcl-2 gene transfer increases relative resistance of S49.1 and WEHI7.2 lymphoid cells to cell death and DNA fragmentation induced by glucocorticoids and multiple chemotherapeutic drugs. , 1992, Cancer research.
[13] J. Lotem,et al. Induction of dependence on hematopoietic proteins for viability and receptor upregulation in differentiating myeloid leukemic cells. , 1989, Blood.
[14] Yi-Song Wang,et al. Wild-type p53-triggered apoptosis is inhibited by bcl-2 in a v-myc-induced T-cell lymphoma line. , 1993, Oncogene.
[15] C. Thompson,et al. bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death , 1993, Cell.
[16] G. Evan,et al. Cooperative interaction between c-myc and bcl-2 proto-oncogenes , 1992, Nature.
[17] P. Nowell,et al. Cytogenetics of Neoplasia , 1987 .
[18] John Calvin Reed,et al. Inhibition of thymocyte apoptosis and negative antigenic selection in bcl-2 transgenic mice. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[19] J. Hickman,et al. bcl-2 modulation of apoptosis induced by anticancer drugs: resistance to thymidylate stress is independent of classical resistance pathways. , 1993, Cancer research.
[20] M. Dyer,et al. Ultrastructural localization of bcl-2 protein. , 1992, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[21] D. Green,et al. Apoptotic cell death induced by c-myc is inhibited by bcl-2 , 1992, Nature.
[22] W. Bursch,et al. Induction of apoptosis in cultured hepatocytes and in regressing liver by transforming growth factor beta 1. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[23] J. Lotem,et al. Control of programmed cell death in normal and leukemic cells: new implications for therapy. , 1993, Blood.
[24] John Calvin Reed,et al. Bcl-2 oncoprotein blocks chemotherapy-induced apoptosis in a human leukemia cell line. , 1993, Blood.
[25] John Calvin Reed,et al. Cloning and sequencing of a cDNA encoding the rat Bcl-2 protein. , 1994, Gene.
[26] T. Hennet,et al. Expression of BCL-2 protein enhances the survival of mouse fibrosarcoid cells in tumor necrosis factor-mediated cytotoxicity. , 1993, Cancer research.
[27] A. Davies,et al. The proto-oncogene bcl-2 can selectively rescue neurotrophic factor-dependent neurons from apoptosis , 1993, Cell.
[28] Suzanne Cory,et al. bcl-2 transgene inhibits T cell death and perturbs thymic self-censorship , 1991, Cell.
[29] Y. Tsujimoto,et al. Involvement of the bcl-2 gene in human follicular lymphoma. , 1985, Science.
[30] John Calvin Reed,et al. Investigation of the subcellular distribution of the bcl-2 oncoprotein: residence in the nuclear envelope, endoplasmic reticulum, and outer mitochondrial membranes. , 1993, Cancer research.
[31] J. Martinou,et al. Prevention of programmed cell death of sympathetic neurons by the bcl-2 proto-oncogene. , 1992, Science.
[32] D. de Jong,et al. Bcl-2/JH rearrangements in benign lymphoid tissues with follicular hyperplasia. , 1991, Oncogene.
[33] S. Korsmeyer,et al. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programed cell death , 1993, Cell.
[34] S. Korsmeyer,et al. bcl-2 inhibits multiple forms of apoptosis but not negative selection in thymocytes , 1991, Cell.
[35] B. Komm,et al. Stable expression of the calbindin-D28K complementary DNA interferes with the apoptotic pathway in lymphocytes. , 1992, Molecular endocrinology.
[36] John Calvin Reed,et al. Conversion of lytic to persistent alphavirus infection by the bcl-2 cellular oncogene , 1993, Nature.
[37] R. Schreiber,et al. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death , 1990, Nature.
[38] David L. Vaux,et al. Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells , 1988, Nature.
[39] S. Krajewski,et al. Evolutionary conservation of function among mammalian, avian, and viral homologs of the Bcl-2 oncoprotein. , 1994, DNA and cell biology.
[40] John Calvin Reed,et al. Molecular cloning and DNA sequence analysis of cDNA encoding chicken homologue of the Bcl-2 oncoprotein. , 1992, Biochimica et biophysica acta.
[41] J. Cleveland,et al. Constitutive c-myc expression in an IL-3-dependent myeloid cell line suppresses cell cycle arrest and accelerates apoptosis. , 1991, Oncogene.
[42] S. Korsmeyer,et al. bcl-2-Immunoglobulin transgenic mice demonstrate extended B cell survival and follicular lymphoproliferation , 1989, Cell.
[43] D. Bredesen,et al. Bcl-2 inhibition of neural death: decreased generation of reactive oxygen species. , 1993, Science.
[44] D. Bredesen,et al. bcl-2 inhibits death of central neural cells induced by multiple agents. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[45] S. Korsmeyer,et al. Constitutive expression of human Bcl-2 modulates nitrogen mustard and camptothecin induced apoptosis. , 1993, Cancer research.
[46] T. Dexter,et al. Haemopoietic colony stimulating factors promote cell survival by suppressing apoptosis , 1990, Nature.
[47] E. Alnemri,et al. Overexpressed full-length human BCL2 extends the survival of baculovirus-infected Sf9 insect cells. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[48] R. Mertelsmann,et al. Expression of bcl-2 in Burkitt's lymphoma cell lines: induction by latent Epstein-Barr virus genes. , 1992, Blood.
[49] Scott W. Lowe,et al. p53 is required for radiation-induced apoptosis in mouse thymocytes , 1993, Nature.
[50] Y. Tsujimoto,et al. Analysis of the structure, transcripts, and protein products of bcl-2, the gene involved in human follicular lymphoma. , 1986, Proceedings of the National Academy of Sciences of the United States of America.